We designed chemotherapeutic regimens combining docetaxel (TXT) and TPP (THP-ADM, CDDP, PEP) or TXT and TPF (THP-ADM, CDDP, 5 FU) for the treatment of oral squamous cell carcinomas and evaluated their primary effects. Nine patients were treated. Forty milligrams of TXT per square meter was administered on day 2 intravenously. The patients were 6 men and 2 women 43 to 55 years of age (mean age, 50) years at presentation. The primary site was the tongue in 6 patients and the mandibular gingiva in 2. TNM classification was T 2 in 4 patients, T 3 in 2, T 4 in 2, and N 2 b in 2. All cases were M 0.The response rate with a combination of TXT and TPP was 100% (CR 50%, PR 50%) and that with a combination of TXT and TPF was also 100% (CR 50%, PR 50% ) . Among the 5 patients who additionally received surgery, the Ohboshi & Shimozato classification was II B in 3 and N B in 2.The main side effects were febrile neutropenia, anorexia, and stomatitis, but there was no effect on subsequent treatment.We conclude that our chemotherapeutic regimens are effective against oral squamous cell carcinoma.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.